Suppr超能文献

90 天内 D-二聚体升高的急诊患者的诊断和转归。

The Diagnoses and Outcomes of Emergency Patients With an Elevated D-Dimer Over the Next 90 Days.

机构信息

Emergency Department, University Hospital Basel, Switzerland.

Department of Emergency Medicine, Hospital of South West Jutland, Denmark.

出版信息

Am J Med. 2021 Feb;134(2):260-266.e2. doi: 10.1016/j.amjmed.2020.06.009. Epub 2020 Jul 12.

Abstract

BACKGROUND

It is not known what diagnoses are associated with an elevated D-dimer in unselected patients attending emergency departments (ED), nor have their associated outcomes been determined.

METHODS

This was a prospective observational study of 1612 unselected patients attending a Danish ED, with 100% follow-up for 90 days after presentation.

RESULTS

The 765 (47%) ED patients with an elevated D-dimer level (ie, ≥ 0.5 mg/L) were more likely to be admitted to hospital (P <.0001), re-present to health services (P = .02), and die within 90 days (8.1% of patients, P <.0001). Only 10 patients with a normal D-dimer level (1.2%) died within 90 days. Five had chronic obstructive pulmonary disease and infection, and 5 had cancer (4 of whom also had infection). Venous thromboembolism, infection, neoplasia, anemia, heart failure, and unspecified soft tissue disorders were significantly associated with an elevated D-dimer level. Of the 72 patients with venous thromboembolism, 20 also had infection, 8 had cancer, and 4 had anemia. None of the patients with heart failure, stroke, or acute myocardial infarction with a normal D-dimer level died within 90 days.

CONCLUSIONS

In this study, nearly half of all patients attending the ED had an elevated D-dimer level, and these patients were more likely to be admitted to hospital and to re-present to health services or die within 90 days. In this unselected ED patient population, elevated D-dimer levels were found to not only be significantly associated with venous thromboembolism, but to also be associated with infection, cancer, heart failure, and anemia.

摘要

背景

目前尚不清楚在前往急诊部(ED)就诊的未选择患者中,哪些诊断与 D-二聚体升高有关,也尚未确定其相关结局。

方法

这是一项对 1612 名未选择的丹麦 ED 就诊患者进行的前瞻性观察性研究,对患者进行了 90 天的 100%随访。

结果

765 名(47%)D-二聚体水平升高(即≥0.5mg/L)的 ED 患者更有可能住院(P<0.0001)、再次就诊(P=0.02)和在 90 天内死亡(8.1%的患者,P<0.0001)。仅有 10 名 D-二聚体正常的患者(1.2%)在 90 天内死亡。其中 5 例患有慢性阻塞性肺疾病和感染,5 例患有癌症(其中 4 例也患有感染)。静脉血栓栓塞、感染、肿瘤、贫血、心力衰竭和未明确的软组织疾病与 D-二聚体升高显著相关。在 72 例静脉血栓栓塞患者中,20 例同时患有感染,8 例患有癌症,4 例患有贫血。在 D-二聚体正常的心力衰竭、中风或急性心肌梗死患者中,没有患者在 90 天内死亡。

结论

在这项研究中,近一半的 ED 就诊患者 D-二聚体水平升高,这些患者更有可能住院、再次就诊或在 90 天内死亡。在这个未选择的 ED 患者人群中,D-二聚体水平升高不仅与静脉血栓栓塞显著相关,还与感染、癌症、心力衰竭和贫血相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c2b/7354269/578404c96554/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验